Follow the Calmark Sweden AB share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. The latest transaction was reported on 1 April 2021 (Purchase). Among the most active insiders: Camilla Arneving. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Calmark Sweden AB is a Swedish company focused on developing diagnostic tests for newborns. It is listed on the Stockholm Stock Exchange.